 |
|
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Alexis Elbaz, MD, PhD;
James H. Bower, MD;
Brett J. Peterson, BS;
Demetrius M. Maraganore, MD;
Shannon K. McDonnell, MS;
J. Eric Ahlskog, PhD, MD;
Daniel J. Schaid, PhD;
Walter A. Rocca, MD, MPH
Arch Neurol. 2003;60:91-96.
Objective To compare survival in incident cases of Parkinson disease (PD) with survival in subjects free of PD from the general population.
Methods We used the medical records linkage system of the Rochester Epidemiology Project to identify incident cases of PD in Olmsted County, Minnesota, for the period 1976-1995. Cases were matched by age and sex to referent subjects from the same population. For 196 cases and 185 referent subjects, we studied survival between the date of diagnosis of PD (or index date) and death, loss to follow-up, or end of the study (May 1, 2000).
Results The median length of follow-up was 7.2 years for cases and 8.0 years for referent subjects; 110 patients with PD and 79 referent subjects died during follow-up. The median survival was 10.3 years in cases and 13.4 years in referent subjects. The relative risk (RR) of death was 1.60 (95% confidence interval [CI], 1.20-2.14; P = .002) overall, 1.81 (95% CI, 1.15-2.84; P = .01) in women, and 1.49 (95% CI, 1.01-2.20; P = .04) in men. There was a decreasing trend in the RR of death according to age at onset of PD (in tertiles): younger than 67 years, RR, 2.04 (95% CI, 0.99-4.19; P = .05); 67 to 76 years, RR, 1.76 (95% CI, 1.08-2.86; P = .02); and older than 76 years, RR, 1.48 (95% CI, 0.95-2.29; P = .08). Patients with PD who had both rest tremor and pronounced asymmetry had a better prognosis than patients with neither clinical characteristic. Patients with PD who smoked survived better than expected.
Conclusions Patients with PD face a higher risk of death compared with subjects free of PD from the general population. Certain clinical characteristics and smoking modify survival.
From the Departments of Health Sciences Research (Drs Elbaz, Schaid, and Rocca, Mr Peterson, and Ms McDonnell) and Neurology (Drs Bower, Maraganore, Ahlskog, and Rocca), Mayo Clinic and Mayo Foundation, Rochester, Minn.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study
Driver et al.
Neurology 2008;70:1423-1430.
ABSTRACT
| FULL TEXT
Estimated life expectancy of Parkinson's patients compared with the UK population
Ishihara et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1304-1309.
ABSTRACT
| FULL TEXT
Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients With Parkinson Disease
Arabia et al.
Arch Gen Psychiatry 2007;64:1385-1392.
ABSTRACT
| FULL TEXT
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Ritz et al.
Arch Neurol 2007;64:990-997.
ABSTRACT
| FULL TEXT
Essential tremor: predictors of disease progression in a clinical cohort.
Putzke et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1235-1237.
ABSTRACT
| FULL TEXT
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore et al.
JAMA 2006;296:661-670.
ABSTRACT
| FULL TEXT
Prognosis of Parkinson Disease: Risk of Dementia and Mortality: The Rotterdam Study
de Lau et al.
Arch Neurol 2005;62:1265-1269.
ABSTRACT
| FULL TEXT
Parkinson disease: Handedness predicts asymmetry
Uitti et al.
Neurology 2005;64:1925-1930.
ABSTRACT
| FULL TEXT
Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort
Marras et al.
Neurology 2005;64:87-93.
ABSTRACT
| FULL TEXT
OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs. 2003;6:e1-12.
FULL TEXT
|
